Practices and attitudes toward complementary and alternative medicine in inflammatory bowel disease: A survey of gastroenterologists

Journal of Complementary and Integrative Medicine

Volumn 11, Issue 4, 2014, Pages 297-303

  Gallinger, Zane R ^a   Nguyen, Geoffrey C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

complementary and alternative medicine; Crohn's disease; inflammatory bowel disease; ulcerative colitis

Indexed keywords

CANNABIS; CURCUMIN; FISH OIL; PREBIOTIC AGENT; PROBIOTIC AGENT;

ACUPUNCTURE; ALOE VERA; ALTERNATIVE MEDICINE; ANDROGRAPHIS PANICULATA; ARTEMISIA VULGARIS; ARTICLE; BOSWELLIA SERRATA; CHINESE MEDICINE; CONVERSATION; DOCTOR PATIENT RELATION; GASTROENTEROLOGIST; HERBAL MEDICINE; HUMAN; INFLAMMATORY BOWEL DISEASE; LIKERT SCALE; MASSAGE; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; MEDITATION; PHYSICIAN ATTITUDE; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; VEGETARIAN DIET;

EID: 84964289598     PISSN: None     EISSN: 15533840     Source Type: Journal    
DOI: 10.1515/jcim-2014-0008     Document Type: Article

References (26)

1. Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 2002;97:382-8.
2. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the united states, 1990-1997: results of a follow-up national survey. J Am Med Assoc 1998;280:1569-75.
3. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, et al. Long-term trends in the use of complementary and alternative medical therapies in the united states. Ann Intern Med 2001;135:262-8.
4. Limdi JK, Butcher RO. Complementary and alternative medicine use in inflammatory bowel disease. Inflamm Bowel Dis 2011;17: E86-8.
5. Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med 2006;6:19.
6. Hilsden R. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. Am J Gastroenterol 2003;98:1563-8.
7. Weizman AV, Ahn E, Thanabalan R, Leung W, Croitoru K, Silverberg MS, et al. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. Aliment Pharmacol Ther 2011;35:342-9.
8. Ganguli SC, Cawdron R, Irvine EJ. Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic? Am J Gastroenterol 2004;99:319-26.
9. Langmead L, Rampton D. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther 2006;23:341-9.
10. Moser G, Tillinger W, Sachs G, Maier-Dobersberger T, Wyatt J, Vogelsang H, et al. Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res 1996;40:503-9.
11. Kelwala S. Why patients use alternative medicine. J Am Med Assoc 1998;280:1660-1.
12. Hilsden RJ, Verhoef MJ. Complementary and alternative medicine: evaluating its effectiveness in inflammatory bowel disease. Inflamm Bowel Dis 1998;4:318-23.
13. Barnes J. Pharmacovigilance of herbal medicines. Drug Saf 2003;26:829-51.
14. Niggemann B, Grüber C. Side-effects of complementary and alternative medicine. Allergy 2003;58:707-16.
15. Wetzel MS, Kaptchuk TJ, Haramati A, Eisenberg DM. Complementary and alternative medical therapies: implications for medical education. Ann Intern Med 2003;138:191-6.
16. Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, DeBruyn JC. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:655-62.
17. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-52.
18. Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology 2002;11:212-20.
19. Koretz RL, Rotblatt M. Complementary and alternative medicine in gastroenterology: the good, the bad, and the ugly. Clin Gastroenterol Hepatol 2004;2:957-67.
20. Golnik AE, Ireland M. Complementary therapy medicine for children with autism: a physician survey. J Autism Dev Disord 2009;39:996-1005.
21. O'Beirne M, Verhoef M, Paluck E, Herbert C. Complementary therapy use by cancer patients. Physicians' perceptions, attitudes, and ideas. Can Fam Physician 2004;50:882-8.
22. Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis 2000;6:107-15.
23. Kruis W. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004;53:1617-23.
24. Durber J, Otley A. Complementary and alternative medicine in inflammatory bowel disease: keeping an open mind. Expert Rev Clin Immunol 2005;1:277-92.
25. Ernst E, Sherman KJ. Is acupuncture a risk factor for hepatitis? Systematic review of epidemiological studies. J Gastroenterol Hepatol 2003;18:1231-6.
26. Maha N, Shaw A. Academic doctors' views of complementary and alternative medicine (CAM) and its role within the NHS: an exploratory qualitative study. BMC Complement Altern Med 2007;7:17.